| MTD |
Report |
Net sales |
IN-LINE |
pred ~$1.037B vs. cons $1.030B |
MEDIUM |
| MTD |
Report |
Adjusted operating EPS |
IN-LINE |
pred ~$10.86 vs. cons $10.81 |
MEDIUM |
| MTD |
Report |
Organic growth |
BEAT |
pred ~2.4% vs. cons 2.03% |
MEDIUM |
| MTD |
Guide |
Q3 adjusted EPS |
UNCHANGED |
guide ~$12.05-$12.20 vs. cons $12.14 |
MEDIUM |
| MTD |
Guide |
FY26 adjusted EPS |
UNCHANGED |
guide ~$46.30-$46.95 vs. cons $46.72 |
MEDIUM |
| MTD |
Guide |
Q3 local-currency sales |
BETTER |
guide ~4% vs. cons 3.59% organic growth UNVERIFIED metric match |
LOW |
| MTD |
Guide |
FY26 local-currency sales |
BETTER |
guide ~4% vs. cons 3.04% organic growth UNVERIFIED metric match |
LOW |
| MTD |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| MTD |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — in-line package leaves forward estimates largely unchanged |
LOW |